Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPIT: Everolimus for TSC-related Neuropsychological Deficits
NCT01730209Phase 3Unknown
- Sponsor
- Erasmus MC
- Start
- Nov 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in tuberous sclerosis complex (TSC), sponsored by Erasmus MC. Status: unknown.
02
Drugs
everolimus
03
Conditions
tuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on NCT01730209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01730209.